
Redox Biology, Год журнала: 2025, Номер 81, С. 103552 - 103552
Опубликована: Фев. 15, 2025
Язык: Английский
Redox Biology, Год журнала: 2025, Номер 81, С. 103552 - 103552
Опубликована: Фев. 15, 2025
Язык: Английский
Cancers, Год журнала: 2024, Номер 16(19), С. 3254 - 3254
Опубликована: Сен. 24, 2024
Short peptides have been coming around as a strong weapon in the fight against cancer on all fronts—in immuno-, chemo-, and radiotherapy, also combinatorial approaches. Moreover, short relevance imaging or 3D culture. Thanks to natural ‘smart’ nature of peptides, their unique structural features, well recent progress biotechnological bioinformatics development, are playing an enormous role evolving cutting-edge strategies. Self-assembling may create excellent structures stimulate cytotoxic immune responses, which is essential for immunotherapy. can help establish versatile strategies with high biosafety effectiveness. Supramolecular peptide-based vaccines entered clinical trials. Peptide assemblies be platforms delivery antigens, adjuvants, cells, and/or drugs. unappreciated, especially vaccine aspect. Meanwhile, they still hide undiscovered unlimited potential. Here, we provide timely update this highly active fast-evolving field.
Язык: Английский
Процитировано
4Redox Biology, Год журнала: 2025, Номер 81, С. 103552 - 103552
Опубликована: Фев. 15, 2025
Язык: Английский
Процитировано
0